EC Approves Giotrif for Lung Cancer – Drug Discovery & Development

by lowes1 on September 26, 2013


Drug Discovery & Development
EC Approves Giotrif for Lung Cancer
Drug Discovery & Development
(Source: Boehringer Ingelheim) Boehringer Ingelheim announced that the European Commission has granted marketing authorization for afatinib monotherapy, for the treatment of Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with 
Lung Cancer, A Deathly Danger Has New OptionsWebProNews
BI personalised NSCLC drug approved in EuropePharmaTimes

all 3 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: